Rocket Pharmaceuticals, Inc. ( RCKT) - Stock Earnings

RCKT Upcoming earnings

Estimated EPS and revenue columns are available to paid members.

Date EPS (actual / est.) Revenue low (est.) Revenue (actual / est.) Revenue high (est.)
Nov. 12, 2026 AfterMarket — / — — — / — —

RCKT Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2026Q1 -47.6 million USD — USD
2026Q2 123.2 million USD — USD
2026Q3 -49.2 million USD — USD
2026Q4 Est. — —
2027Q1 Est. — —
2027Q2 Est. — —

RCKT Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -245.6 million USD — USD
2024 -258.7 million USD — USD
2025 -223.1 million USD — USD
2026 Est. — —

RCKT

Price: $2.16

52 week price:
2.11
8.26

Earnings Per Share: -0.15 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 607900

Market Capitalization: 256.8 million

Links: